Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:e87

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenna, C. J.
Right arrow Articles by Yokota, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenna, C. J.
Right arrow Articles by Yokota, M.
Related Collections
Right arrow Platelets
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 1999;100:e87.)
© 1999 American Heart Association, Inc.


Circulation Electronic Pages

Familial Dilated Cardiomyopathy

Charles J. McKenna, MD, MRCP

Department of Cardiology Royal Infirmary, Edinburgh, Scotland


*    Introduction
 
To the Editor:

The article by Ichihara and colleagues published in the November 3, 1998, issue of Circulation describes an association between a G994->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene and genetic susceptibility to nonfamilial dilated cardiomyopathy (DCM).1 No definition of nonfamilial DCM is offered. Prospective studies in which relatives of patients with DCM were screened by echocardiography have consistently demonstrated a familial prevalence of at least 25%.2 3 4 However, the majority of these relatives are asymptomatic despite demonstrating ongoing disease activity.5 Thus, it is not possible to estimate the frequency of familial DCM by history-taking alone. It is conceivable that the patients with DCM demonstrating the gene mutation in the article in question would show a familial tendency if their first-degree relatives were screened by echocardiography. I would be interested to know how familial DCM was excluded in the study and whether any attempt was made to classify familial cases by echocardiographic screening.


*    References
 
1. Ichihara S, Yamada Y, Yokota M. Association of a G994->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese. Circulation. 1998;98:1881–1885.[Abstract/Free Full Text]

2. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77–82.[Abstract]

3. Keeling PJ, Gang Y, Smith G, Seo H, Bent SE, Murday V, Caforio AL, McKenna WJ. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J. 1995;73:417–421.[Abstract/Free Full Text]

4. McKenna CJ, Codd MB, McCann HA, Sugrue DD. Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution. Heart. 1997;77:549–552.[Abstract/Free Full Text]

5. McKenna CJ, Sugrue DD, Kwon HM, Sangiorgi G, Carlson PJ, Mahon N, McCann HA, Edwards WD, Holmes DR, Schwartz RS. Histopathologic changes in asymptomatic relatives of patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 1999;83:281–283.[Medline] [Order article via Infotrieve]

Response

Sahoko Ichihara, MD

First Department of Internal Medicine Nagoya University School of Medicine, Nagoya, Japan

Yoshiji Yamada, MD, PhD

Department of Geriatric Research National Institute for Longevity Sciences, Obu, Japan

Mitsuhiro Yokota, MD, PhD, FACC

Department of Clinical Laboratory Medicine Nagoya University School of Medicine, Nagoya, Japan


*    Introduction 
 
We thank Dr McKenna for his valuable comments on our study. In the study published in the November 3, 1998, issue of Circulation,1 we determined the absence of a family history of patients with dilated cardiomyopathy (DCM) by use of a detailed questionnaire. We have confirmed that there were no relatives diagnosed with DCM, heart failure, or severe arrhythmia or who experienced documented sudden death. However, we have not performed echocardiographic screening in patients' relatives. Although accurate data for the frequency of familial prevalence are currently not available in Japan, familial DCM . . . [Full Text of this Article]